Karacin, CengizOksuzoglu, BernaDemirci, AyseKeskinkilic, MerveBaytemur, Naziyet KoseYilmaz, FundaSelvi, Oguzhan2024-09-182024-09-1820231471-2407https://doi.org/10.1186/s12885-023-10662-3https://hdl.handle.net/20.500.12483/13677[Abstract Not Available]eninfo:eu-repo/semantics/openAccessEfficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)Correction23110.1186/s12885-023-10662-3368499432-s2.0-85148970683Q2WOS:000941147400001Q2